Stock Rich List
#663 on the rich list of 14,644 insiders

Paul B. Manning

Director at Liquidia; 10% owner at Taysha Gene Therapies; Director at Candel Therapeutics. Based in Charlottesville, Virginia.

$311M
in disclosed stock, −$5.2M (−1.64%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
663rd of 14,644
Companies held
4
Largest holding
LQDA, 55.6% of total
Latest SEC filing
Jun 16, 2026

What the $311M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Taysha Gene Therapies TSHA
Common Stock
Through Paul B. Manning Revocable Trust14,723,948$3.77$55.5M17.8%Form 4, May 30, 2025
Liquidia LQDA
Common Stock
Through Paul B. Manning Revocable Trust798,335$56.63$45.2M14.5%Form 4, Jun 16, 2026
Liquidia LQDA
Common Stock
Through BKB Growth Investments, LLC716,311$56.63$40.6M13.0%Form 4, Jun 16, 2026
Liquidia LQDA
Common Stock
Directly475,465$56.63$26.9M8.7%Form 4, Jun 16, 2026
Liquidia LQDA
Common Stock
Through PBM Capital Finance, LLC435,674$56.63$24.7M7.9%Form 4, Jun 16, 2026
Liquidia LQDA
Common Stock
Through PBM 2024 Grantor Retained Annuity Trust430,828$56.63$24.4M7.8%Form 4, Sep 2, 2025
Taysha Gene Therapies TSHA
Common Stock
Through PBM 2025 Grantor Retained Annuity Trust4,000,000$3.77$15.1M4.8%Form 4, May 30, 2025
Candel Therapeutics CADL
Common Stock
Through Paul B. Manning Revocable Trust2,763,527$5.13$14.2M4.6%Form 4, Feb 23, 2026
Verrica Pharmaceuticals VRCA
Common Stock
Directly3,958,189$2.89$11.4M3.7%Form 4, Nov 25, 2025
Liquidia LQDA
Common Stock
Through PD Joint Holdings, LLC198,413$56.63$11.2M3.6%Form 4, Jun 16, 2026
Taysha Gene Therapies TSHA
Common Stock
Through BKB Growth Investments, LLC2,841,704$3.77$10.7M3.4%Form 4, May 30, 2025
Verrica Pharmaceuticals VRCA
Common Stock
Through BKB Growth Investments, LLC3,348,372$2.89$9.7M3.1%Form 4, Nov 25, 2025
Candel Therapeutics CADL
Common Stock
Directly1,681,000$5.13$8.6M2.8%Form 4, Feb 23, 2026
Candel Therapeutics CADL
Common Stock
Through BKB Growth Investments, LLC1,303,752$5.13$6.7M2.1%Form 4, Feb 23, 2026
Taysha Gene Therapies TSHA
Common Stock
Directly1,333,333$3.77$5.0M1.6%Form 4, Jun 27, 2024
Verrica Pharmaceuticals VRCA
Common Stock
Through trust332,433$2.89$959K0.3%Form 4, Nov 25, 2025
Verrica Pharmaceuticals VRCA
Common Stock
Through trust89,187$2.89$257K0.1%Form 4, Nov 25, 2025
Taysha Gene Therapies TSHA
Common Stock
Through BKB G2 Investments, LLC22,000$3.77$83K0.0%Form 4, May 30, 2025
Verrica Pharmaceuticals VRCA
Common Stock
Through PBM Capital Investments, LLC25,663$2.89$74K0.0%Form 4, Nov 25, 2025

Share counts are the amounts Paul B. Manning reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 4, 2026SoldLQDA19,125$62.62$1.2MView
Jun 4, 2026SoldLQDA68,265$63.83$4.4MView
Jun 4, 2026SoldLQDA88,487$64.28$5.7MView
Jun 4, 2026SoldLQDA11,513$63.13$727KView
Jun 4, 2026SoldLQDA12,610$64.42$812KView
Feb 23, 2026BoughtCADL550,458$5.45$3.0MView
Nov 25, 2025BoughtVRCA1,375,380$4.24$5.8MView
Nov 25, 2025BoughtVRCA2,750,762$4.24$11.7MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
660Tunc Doluca
Director, Analog Devices. San Jose, CA
$315M−$2.8M (−0.88%)
661Christina Tan
Director, Pangaea Logistics Solutions. Stamford, CT
$314M−$3.8M (−1.19%)
662Charles H. Giancarlo
CEO, Everpure. Santa Clara, CA
$314M+$11.4M (+3.76%)
663Paul B. Manning
Director, Liquidia. Charlottesville, VA
$311M−$5.2M (−1.64%)
664David Nanus
10% owner, NRG Energy. New York, NY
$310M+$627K (+0.20%)
665Richard B. Leeds
Executive Chairman, Global Industrial. Port Washington, NY
$309M−$5.9M (−1.88%)
666Michael K. Lester
President and CEO, LifeStance Health Group. Scottsdale, AZ
$309M−$10.0M (−3.12%)

Other Liquidia insiders

All LQDA insiders

Questions

How much stock does Paul B. Manning own?

Paul B. Manning holds $311,276,747 in listed stock based on SEC filings and current prices, mostly Taysha Gene Therapies (TSHA). That ranks 663rd on the Stock Rich List.

Is this Paul B. Manning's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Paul B. Manning last buy or sell stock?

The most recent open-market trade on file is a sale of 19,125 LQDA shares on Jun 4, 2026 at $62.62.